Search Results for "Grifols Biomat Employee Portal"

13:14 EST 28th January 2015 | BioPortfolio

Original Source: Grifols, Inc.

Currently, we supply plasma products, diagnostic reagents, automated analyzers and dosing machines.In 1998, Grifols established a joint venture with a US diagnostic company, Quest International. Then, in 2000 in order to prepare for an even greater presence in the USA with its plasma products, Grifols founded Grifols USA.Grifols acquired SeraCare’s network of 45 plasmapheresis centers in 2002, thereby vertically integrating the company and guaranteeing its supply of plasma. A year later, Grifols acquired ...

Matching Channels

Matching News

BRIEF-Spain's Grifols US purification plant cleared by regulator

* Says U.S. Food and Drug Administration has given the green light to a new Grifols Biologicals Inc. purification plant in Los Angeles, California

FDA approves Grifols' plasma fractionation unit

The FDA has approved Grifols' installation of a blood plasma unit at its plant in North Carolina.  -More- 

Grifols gets CE mark for hepatitis E detection test

Grifols has earned the CE mark in Europe for the Procleix HEV test, which it developed with Hologic.  -More- 

Spain's Grifols' U.S. plasma installation cleared by FDA

MADRID, Nov 17 (Reuters) - Spanish healthcare firm Grifols said on Monday it had been given the green light to go ahead with a new blood plasma installation in Clayton, North Carolina, by the U.S. Foo...

Grifols Announces FDA Approval of Plasma Fractionation Unit

Spanish-based healthcare company, Grifols, announced that FDA approved the expansion of the plasma fractionation unit at its Clayton, North Carolina facility.

Spain's Grifols adj net profit up 29.4 pct, beats forecasts

MADRID, Nov 4 (Reuters) - Spain's Grifols posted a better-than expected 29.4 percent rise in adjusted net profit to 435.2 million euros (544.04 million US dollar) for the nine months to September, bac...

Spain's Grifols H1 adjusted profit up 25 pct, misses fcasts

MADRID, July 31 (Reuters) - Spanish healthcare firm Grifols said first half adjusted net profit rose 25 percent on Thursday, slightly below analysts' expectations in a Reuters poll and boosted by the ...

Grifols introduces 2000 FVIII IU ALPHANATE assay

Spanish producer of plasma-derived medicines Grifols has launched a 2000 IU/vial assay size for ALPHANATE (antihemophilic factor/von Willebrand factor complex [human]).

Matching PubMed Articles

Nitrate Removal in Shallow, Open-Water Treatment Wetlands.

The diffuse biomat formed on the bottom of shallow, open-water unit process wetland cells contains suboxic zones that provide conditions conducive to NO3(-) removal via microbial denitrification, as w...

Absent portal vein bifurcation: a rare variant and its clinical significance.

Portal vein branching anomaly occurs due to aberration of normal anastomotic patterns and involution of vitelline veins during development of portal vein. Anatomical knowledge of portal vein and its b...

Assessment of percutaneous transhepatic portal vein embolization with portal vein stenting for perihilar cholangiocarcinoma with severe portal vein stenosis.

The aim of the present study was to assess the clinical efficiency of portal vein (PV) stenting when performed with preoperative percutaneous transhepatic portal vein embolization (PTPVE) in patients ...

Shift Work and Employee Fatigue: Implications for Occupational Health Nursing.

Long work hours and irregular shifts are part of the nation's 24-hour society and contribute to employee fatigue. Factors affecting employee fatigue are circadian rhythm, sleep quality and quantity, i...

Portal hypertension: A critical appraisal of shunt procedures with emphasis on distal splenorenal shunt in children.

Extrahepatic portal venous obstruction (EHPVO) is the most common cause of pediatric portal hypertension. We analyzed the investigative protocol and results of portosystemic shunts in this group of pa...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement